Clinical Trials
39 trialsPREVENT HPV -Related Cancers Trial
University of Utah
V503-023
Merck Sharp & Dohme LLC
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients
National Cancer Institute (NCI)
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
National Institutes of Health Clinical Center (CC)
9vHPV-BCG
Medicine Invention Design, Inc
SHIP-A-S01
National Cancer Institute (NCI)
LMI-001-A-S03
National Cancer Institute (NCI)
LMI-001-A-S02
National Cancer Institute (NCI)
Intradermal, Fractional Dose of HPV Vaccines:
University of Washington
Immunogenicity of Fractional Dose of the HPV Vaccines
University of Washington
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen
Boston Medical Center
Gamified Learning Methods and HPV Knowledge in Nursing Students
Aydin Adnan Menderes University
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
Eastern Cooperative Oncology Group
Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care
Roswell Park Cancer Institute
Self-TI
Queen Mary University of London
Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts
Antiva Biosciences
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
Weill Medical College of Cornell University
Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging
National Vaccine and Serum Institute, China
Promoting HPV Vaccination Among Young Adults in Texas
M.D. Anderson Cancer Center
APOSY
Assistance Publique - Hôpitaux de Paris
PARENT
Ohio State University Comprehensive Cancer Center
QoLATI
Rigshospitalet, Denmark
ULACNet-202
Weill Medical College of Cornell University
Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement
Baylor College of Medicine
Add-Vacc
London School of Hygiene and Tropical Medicine
ESCUDDO
National Cancer Institute (NCI)
Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
Jonsson Comprehensive Cancer Center
SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening
Teal Health, Inc.
Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis
Precigen, Inc
anal HSIL HIV-
Frantz Viral Therapeutics, LLC
V503-069
Merck Sharp & Dohme LLC
AI-DSS
University Medical Center Groningen
V503-049
Merck Sharp & Dohme LLC
A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years
Shanghai Bovax Biotechnology Co., Ltd.
Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)
Merck Sharp & Dohme LLC
9-VPH-MVIH
University Hospital Virgen de las Nieves
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years
Sinocelltech Ltd.
A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China
Beijing Health Guard Biotechnology, Inc
V503-071
Merck Sharp & Dohme LLC